What caused the recent drop in Neovacs stock?

The drop is largely due to financial instability, with a massive EPS loss and declining investor confidence reflected in the market cap and stock price.

What is the current price of Neovacs S.A. stock?

The current price is €0.009, marking a significant drop from the previous close at €1.8 on EURONEXT trading platform in Europe. [More Info](https://meyka.com/stocks/ALNEV.PA)

How does Meyka AI rate Neovacs S.A. stock?

Meyka AI rates it with a score of 62 and suggests a HOLD, considering multiple financial and market factors despite current negative indicators. Forecasts indicate potential further downside.

What are the technical indicators for Neovacs?

Key indicators include an RSI of 27.10 (oversold) and a bearish MACD at -0.04. The ADX indicates a strong negative trend at 28.94, suggesting further drop potential.

Is Neovacs S.A. a good investment currently?

Given the current financial challenges and stock volatility, potential investors should proceed with caution. It's crucial to conduct thorough personal research or consult with a financial advisor.

EU Stocks

Neovacs S.A. Drops -97.96111%: Reasons Behind Selloff

ByHuzaifa Zahoor December 25, 2025December 25, 2025

Neovacs S.A. (ALNEV.PA) has witnessed a catastrophic decline in its stock price, plummeting by -97.96111% recently. Trading on the EURONEXT, the company’s current price stands at just €0.009, a startling fall from its previous close of €1.8. This article delves into the reasons behind this massive selloff.